StreetInsider.com News Articles

Laboratory Corporation of America (LH) PT Raised to $338 at Baird

Mon, 13 Jul 2026 07:20:36 -0400

Baird analyst Eric Coldwell raised the price target on Laboratory Corporation of America (NYSE: LH) to $338.00 (from $335.00) while maintaining a Outperform rating.

Form 8-K LABCORP HOLDINGS INC. For: Jul 08

Fri, 10 Jul 2026 07:32:00 -0400

si-local-file:///var/storage/secattach/20260710/26755236.html

Form 8-K LABCORP HOLDINGS INC. For: Jul 08

Fri, 10 Jul 2026 07:32:00 -0400

si-local-file:///var/storage/secattach/20260710/26755236.html

Labcorp (LH) Declares $0.72 Quarterly Dividend; 1% Yield

Thu, 09 Jul 2026 17:07:23 -0400

Labcorp (NYSE: LH) declared a quarterly dividend of $0.72 per share, or $2.88 annualized.

The dividend will be payable on September 11, 2026, to stockholders of record on August 28, 2026, with an ex-dividend date of August 27, 2026.

The annual yield on the dividend is 1 percent.

For a dividend history and other dividend-related data on Labcorp (LH) click here.

Labcorp Declares Quarterly Dividend

Thu, 09 Jul 2026 17:05:00 -0400

BURLINGTON, N.C., July 9, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 11, 2026, to stockholders of record as of the close of business on August 28, 2026.

Labcorp Declares Quarterly Dividend

Thu, 09 Jul 2026 17:05:00 -0400

Labcorp Declares Quarterly Dividend

Thu, 09 Jul 2026 17:05:00 -0400

Labcorp Declares Quarterly Dividend

Thu, 09 Jul 2026 17:05:00 -0400

Form 4 LABCORP HOLDINGS INC. For: Jul 01 Filed by: Kyle Kathryn W

Mon, 06 Jul 2026 09:38:00 -0400

si-local-file:///var/storage/secattach/20260706/26733680.html

Form 4 LABCORP HOLDINGS INC. For: Jul 01 Filed by: Kyle Kathryn W

Mon, 06 Jul 2026 09:38:00 -0400

si-local-file:///var/storage/secattach/20260706/26733680.html

Form 4 LABCORP HOLDINGS INC. For: Jul 01 Filed by: Vaughn Bryan T

Mon, 06 Jul 2026 09:37:00 -0400

si-local-file:///var/storage/secattach/20260706/26733678.html

Form 4 LABCORP HOLDINGS INC. For: Jul 01 Filed by: Vaughn Bryan T

Mon, 06 Jul 2026 09:37:00 -0400

si-local-file:///var/storage/secattach/20260706/26733678.html

Form 144 LABCORP HOLDINGS INC. Filed by: Kyle Kathryn W

Thu, 02 Jul 2026 12:20:00 -0400

si-local-file:///var/storage/secattach/20260702/26725879.html

Form 144 LABCORP HOLDINGS INC. Filed by: Kyle Kathryn W

Thu, 02 Jul 2026 12:20:00 -0400

si-local-file:///var/storage/secattach/20260702/26725879.html

Form 144 LABCORP HOLDINGS INC. Filed by: Vaughn Bryan T

Thu, 02 Jul 2026 10:29:00 -0400

si-local-file:///var/storage/secattach/20260702/26725210.html

Form 144 LABCORP HOLDINGS INC. Filed by: Vaughn Bryan T

Thu, 02 Jul 2026 10:29:00 -0400

si-local-file:///var/storage/secattach/20260702/26725210.html

Form 144 LABCORP HOLDINGS INC. Filed by: van der Vaart Sandra D

Wed, 01 Jul 2026 10:03:00 -0400

si-local-file:///var/storage/secattach/20260701/26718293.html

Form 144 LABCORP HOLDINGS INC. Filed by: van der Vaart Sandra D

Wed, 01 Jul 2026 10:03:00 -0400

si-local-file:///var/storage/secattach/20260701/26718293.html

Form 8-K LABCORP HOLDINGS INC. For: Jun 30

Tue, 30 Jun 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260630/26713906.html

Form 8-K LABCORP HOLDINGS INC. For: Jun 30

Tue, 30 Jun 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260630/26713906.html

Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026

Tue, 30 Jun 2026 16:15:00 -0400

BURLINGTON, N.C., June 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on Thursday, July 30, 2026. The company will host a webcast beginning at 9:00 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the "News & Events" section of the Labcorp Investor Relations website at

Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026

Tue, 30 Jun 2026 16:15:00 -0400

Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026

Tue, 30 Jun 2026 16:15:00 -0400

Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026

Tue, 30 Jun 2026 16:15:00 -0400

Labcorp makes RNA-based colorectal cancer home test available nationwide

Mon, 22 Jun 2026 07:02:37 -0400

Labcorp (NYSE: LH) announced the nationwide availability of ColoSense®, an RNA-based at-home colorectal cancer screening test developed by Geneoscopy, through a commercial collaboration between the two companies.

ColoSense is the only RNA-based at-home colorectal cancer screening test approved by the U.S. Food and Drug Administration. The test detects biomarkers associated with colorectal cancer and advanced adenomas. It received FDA Breakthrough Device Designation and is included in screening guidelines from the American Cancer Society and the National Comprehensive Cancer Network.

The test is now covered for eligible Medicare and Medicare Advantage beneficiaries following a Centers for Medicare & Medicaid Services update to the